SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (201)12/10/1998 8:37:00 AM
From: Street Walker  Read Replies (2) of 1084
 
As a physician who has dug out marrow from bones...
this technology is extremely exciting. I'm glad to
hear it is already being used in the United States
even without FDA approval. Shows us what the FDA thinks about it.
Studies look extremely positive. It is saving lives.

This technology is particularly important because
the cells are specific to each person. The heart ache
in hematology has been not being able to find a "blood match"
This technology solves that. Also, since the blood is
specific for the person, there is no rejection.

Their product is cutting edge. Will be a big money maker.
Launched in Europe in a few weeks.

If it does not gap too high, I would be a buyer.
Dec 12 is the Cancer Meeting and many of my associates
will be buying before going into that meeting.

Good Luck all. This product is exciting. Not just for
cancer, but for infectious diseases, auto-immune disorders,
etc. Their product will become a main-stay in Hematology
Departments across the world. The product will bring in
some incredible revenues.

They IPO'd at $7. They are better off now, than when they
opened up. Why? Their product is about to be launched.

Buying on dips. Wish I had been apart of it yesterday.

Regards,
S.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News